LEAVE NOTHING BEHIND

Minimally Invasive Micro Sclerostomy (MIMS®) is a Stentless, Simple & Fast Glaucoma treatment designed to lower the IOP without the need for invasive surgery.

Story

MIMS® Story

Dr Douglas Argyll Robertson4 (1837-1909) was a Scottish Ophthalmologist and surgeon. Dr roberston was the first to publish a description including post-op results following the use of a trephine in the surgical treatment of glaucoma in late 19th century.This would create a small hole in the sclera (anterior sclerotomy) that would drain aqueous homor to lower IOP.

At the turn of the 20th Century, Dr Robert Henry Elliot5 (1865 – 1936) whom was a British ophthalmic surgeon and also an expert on snake venom published his work on Sclero-corneal trephining in the operative treatment of glaucoma

Read More

A Minimally invasive & Stent-less Treatment Glaucoma Innovation

MIMS® is a rapid & minimally invasive procedure at the forefront of Interventional Glaucoma treatments. Fewer post-op complications allows for effective IOP management.

How MIMS® Works

Minimally Invasive Micro Sclerostomy is fast, accessible & effective. It works by inserting a specially designed cutting tool into the sclera & removing a small channel of tissue. This channel will remain open & contentiously drain, effectively reducing IOP.

A Ready-to-Use Surgical System

MIMS® is a lightweight surgical system intended for use by trained professional ophthalmologists. It’s easy to use & learn, intuitive to operate & requires fewer staff to assist in non-surgical environments. A central control touchscreen demonstrates the surgical parameters & a foot pedal initiates the precise handheld cutting tool movement.

Precision Glaucoma Treatment Technology

Novel Glaucoma treatment practiced globally. Learn more about MIMS® surgical device innovation.

Download Specifications

Outstanding Clinical Performance

85%

Medication reduction from baseline after 1 year1-3

38%

IOP reduction from baseline after 1 and 3 years1-3

73%

Medication reduction from baseline after 3 years1-3

Minimal

Major intra/post-op complications

Explore Clinical Outcomes

MIMS® Testimonials

News & Publications

Courtesy of Chrys Dimitriou, Colchester Eye Centre, Essex, UK
Learn More

References

1. Voskanyan L. et al, « Long Term Results Of Minimally Invasive Micro Sclerostomy (MIMS®)», 10th World Glaucoma Congress, June 30, 2023, Rome Italy, Page 735.

2. Voskanyan L., «Long-term results of Minimally Invasive Micro Sclerostomy (MIMS®)», Poster presented at the 41st Congress of the ESCRS, September 9, 2023, Vienna, Austria.

3. Geffen N., «Ab interno sclerostomy», Glaucoma Surgery: New Techniques on the Horizon, presented at the 10th Congress of the WGC Congress, June 30, 2023 Rome, Italy

4. Robertson D.A., «Trephining the sclerotic: a new operation for glaucoma.», Royal London Ophthalmic Hospital Reports, (Volume 8), 1876.

5. Elliot, R.H., «Sclero-corneal trephining in the operative treatment of glaucoma», 186 Pages, 2nd ed. London: George Pulman & Sons,1914.

6. Junemann A.G.M. and Redfak R., «MIMS – minimally invasive micro-sclerostomy: A new filtering surgical procedure.» Concept Ophtalmology, August 2022.

7. Grover D.S, MD, MPH, «MINIMALLY INVASIVE MICRO SCLEROSTOMY – Reviewing the surgical steps and outcomes for a new filtration procedure.», GLAUCOMA TODAY, 2022.

8. Larkin H., «Stent-less Glaucoma Surgery, Expanded indications sought for minimally invasive technology.», EUROTIME, 2023.

9. «MIMS®: WHERE NOTHING GETS LEFT BEHIND, Introducing a stentless, simple, and rapid glaucoma treatment that effectively lowers IOP without invasive surgery», The Ophtalmologist, 2022.